Online tool detects drug exposure directly from patient samples

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at ...
Le Lézard

Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine

Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for migraine and metabolism, today announced positive results ...

Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca ...